Education
About Us
Working with TipRanks
Follow Us
Altria Group Inc (DE:PHM7)
XETRA:PHM7
PHM7 Stock Chart & Stats
€56.56
-€0.17(-0.33%)
At close: 4:00 PM EST
€56.56
-€0.17(-0.33%)
Day’s Range― - ―
52-Week Range€46.62 - €59.03
Previous CloseN/A
Volume2.27K
Average Volume (3M)9.53K
Market Cap
€94.71B
Enterprise Value€133.32B
Total Cash (Recent Filing)€4.47B
Total Debt (Recent Filing)€25.71B
Price to Earnings (P/E)15.4
Beta0.17
Next Earnings
Apr 30, 2026EPS Estimate
1.05Next Dividend Ex-DateN/A
Dividend Yield7.26%
Share Statistics
EPS (TTM)1.10
Shares Outstanding1,678,671,500
10 Day Avg. Volume11,085
30 Day Avg. Volume9,529
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)-27.61
Price to Sales (P/S)4.80
P/FCF Ratio10.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€55.85Price Target Upside-1.26% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product AuthorizationFDA authorization of on! PLUS nicotine pouches enables Altria to accelerate its shift to smoke-free products and expand its portfolio into authorized flavored pouch offerings.
Tax And Duty BenefitsRising duty drawback benefits and increased import/export activity are expected to generate excise tax savings that support earnings and help offset price investment.
Valuation And Capital AllocationValuation near historic lows combined with a strong balance sheet and a meaningful dividend yield provides scope for increased share repurchases and supports total shareholder return.
Bears Say
Competitive And Product Development RiskLimited progress on reduced-risk products and planned competitor heated tobacco launches increase competitive pressure and could constrain long-term growth prospects.
Premium Volume DeclineContinued pressure on premium cigarette volumes, including Marlboro, risks further revenue decline and could weaken pricing power.
Product Mix HeadwindsGrowth in discount brand volumes has improved aggregate trends but creates negative product mix effects as premium volume falls, compressing margins.
Altria Group News
PHM7 FAQ
What was Altria Group Inc’s price range in the past 12 months?
Altria Group Inc lowest stock price was €46.62 and its highest was €59.03 in the past 12 months.
What is Altria Group Inc’s market cap?
Altria Group Inc’s market cap is €94.71B.
When is Altria Group Inc’s upcoming earnings report date?
Altria Group Inc’s upcoming earnings report date is Apr 30, 2026 which is in 69 days.
How were Altria Group Inc’s earnings last quarter?
Altria Group Inc released its earnings results on Jan 29, 2026. The company reported €1.102 earnings per share for the quarter, missing the consensus estimate of €1.118 by -€0.016.
Is Altria Group Inc overvalued?
According to Wall Street analysts Altria Group Inc’s price is currently Overvalued.
Does Altria Group Inc pay dividends?
Altria Group Inc pays a Quarterly dividend of €0.901 which represents an annual dividend yield of 7.26%. See more information on Altria Group Inc dividends here
What is Altria Group Inc’s EPS estimate?
Altria Group Inc’s EPS estimate is 1.05.
How many shares outstanding does Altria Group Inc have?
Altria Group Inc has 1,678,671,500 shares outstanding.
What happened to Altria Group Inc’s price movement after its last earnings report?
Altria Group Inc reported an EPS of €1.102 in its last earnings report, missing expectations of €1.118. Following the earnings report the stock price went down -4.06%.
Which hedge fund is a major shareholder of Altria Group Inc?
Currently, no hedge funds are holding shares in DE:PHM7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Altria Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€55.85 (-1.26% Downside)
€55.85 (-1.26% Downside)
Blogger Sentiment
Bullish
DE:PHM7 Sentiment 89%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.65%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.45%
Trailing 12-Months
Company Description
Altria Group Inc
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
PHM7 Company Deck
PHM7 Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a mix of positive strategic and financial developments alongside material near‑term challenges. Positives include full‑year EPS growth (4.4%), strong full‑year smokeable margins and net price realization, substantial shareholder returns (~$8B), progress in the nicotine pouch portfolio (ON and ON PLUS FDA authorizations and a planned national rollout), international expansion, and a clear plan to unlock import/export duty‑drawback benefits (with management citing <1 year payback). Offsetting these are meaningful cigarette volume declines (~9–10% FY adjusted), Q4 margin and adjusted OCI pressures in certain segments, intense competitive/promotional activity in nicotine pouches, a large $1.3B noncash e‑vapor impairment, and the ongoing industry headwind from illicit disposable e‑vapor products. Overall, the positives and negatives are roughly balanced — the company shows solid cash generation, strategic progress and guidance for modest EPS growth in 2026, but also faces significant operational and market headwinds that temper near‑term outlook.View all DE:PHM7 earnings summariesPHM7 Revenue Breakdown
88.28% Smokeable products
11.56% Oral tobacco products
0.16% All other
PHM7 Stock 12 Month Forecast
Average Price Target
€55.85
▼(-1.26% Downside)
Technical Analysis
British American Tobacco
―
Philip Morris
―
Universal
―
Turning Point Brands
―
RLX Technology
―
Options Prices
Currently, No data available
---